Nevertheless, our findings are significant because they support and help to explain efficacy of YAP inhibitors in the treatment of cancer, as YAP appears to not only play a pro-oncogenic role in tumor cells but also promotes suppression of both CD4 and CD8 T cells. This evidence concerns the gene CD8A and cancer.